Navigation Links
Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment

intensity compared to patients in the placebo group (p=0.021). When both dose groups of tapentadol were compared to the oxycodone arm of the study (added as sensitivity control of the model), tapentadol ER 100 mg bid was found to be similar to oxycodone HCl CR 20 mg bid, providing further support that the analgesic efficacy of tapentadol is in the range of other strong centrally acting analgesics.

Safety and Tolerability - In general, the most common adverse events in all groups were typical for a treatment with centrally acting analgesics. With respect to gastrointestinal (e.g. nausea, vomiting, constipation) and CNS (e.g.

somnolence, dizziness) side effects, the data suggest an improved tolerability of tapentadol compared to oxycodone. The incidence of constipation with both tapentadol ER 100 mg (7%) and 200 mg (10%) was less than or equal to half of the incidence associated with oxycodone CR 20 mg (20%).

Tapentadol Co-Development Partnership - Tapentadol is the latest innovation coming out of Grunenthal's R&D pipeline. Grunenthal and Ortho-McNeil Pharmaceutical, Inc, based in Raritan, NJ, United States, began working together on tapentadol in 2003 with a licensing agreement for the United States and Canada. The companies are co-developing tapentadol in the United States, Canada, and the European Union. In January 2007, Grunenthal announced the extension of the licensing agreement with Ortho-McNeil Pharmaceutical to include the Japanese market.

About Grunenthal - Grunenthal is an expert in pain therapy and gynaecology and a pioneer in intelligent, user-friendly drug delivery technologies. The company discovers, develops, produces and markets high therapeutic value pharmaceuticals that contribute to patients' ability to control their own lives. Grunenthal is an independent, family-owned German company operating with affiliates in 27 countries all over the world. Founded in 1946, t
'"/>




Page: 1 2 3

Related medicine news :

1. SARS-Free Taiwan to Mark End Phase of Global Fight
2. Spray on contraceptive clears Phase I trial
3. Phase 3 trials of two multi-kinase inhibitors against cancer
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. Phase II trails of new HIV vaccine to be held in South Africa
6. FDA approves Phase 0 trial which tests experimental drugs on humans
7. Jalgaon: Third Phase Of Culling Operations Begin
8. Phase 1 Drug Trials on Humans to Be Made Public
9. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
10. Cadila to Commence Phase I Clinical Trials On ZYH2
11. iGATE Completes Phase I Testing Of Meningitis Vaccine
Post Your Comments:
(Date:9/18/2014)... Mateo, CA (PRWEB) September 18, 2014 ... archiving solutions, from active, to medium, and even long ... of content for any length of time. This includes ... of machine-produced data. When used together, Nautilus and ASG-Digital ... managing archive content. , "storageFOUNDRY is pleased to ...
(Date:9/17/2014)... Recently, UWDress.com, an innovative company that ... occasion outfits, has released its 2014 empire waist ... has launched a big sale for these new and ... deeply discounted rates, from 15 to 65 percent off. ... on using comfortable to wear materials. Its elegant items ...
(Date:9/17/2014)... 18, 2014 According to Centers for ... treat an estimated 173,285 sports- and recreation-related traumatic brain ... Soon, a blood test may be available to help ... long recovery will take. , In March of ... have found a way to test blood for a ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 According ... Drug Administration report titled “Adverse Events Associated with ... a Dermal Filler,” unapproved use of Expression, a ... resulted in adverse reactions including discoloration, lumps, bruising, ... with FDA approval for cosmetic use include ...
(Date:9/17/2014)... Final Cut Pro X plugin developers have ... Pixel Film Studios. , “ProBlue 5k is a compilation of ... to epic,” said Christina Austin, CEO of Pixel Film Studios. ... a definite game changer.” , ProBlue 5k is the ultimate ... filmmaker ! This footage compilation of over 100 anamorphic flares ...
Breaking Medicine News(10 mins):Health News:storageFOUNDRY and ASG Software Solutions Partner to Integrate ASG-Digital Archive with the Nautilus Software-Defined Storage Platform 2Health News:storageFOUNDRY and ASG Software Solutions Partner to Integrate ASG-Digital Archive with the Nautilus Software-Defined Storage Platform 3Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:Breakthrough blood test will improve concussion diagnoses, treatment 2Health News:Breakthrough blood test will improve concussion diagnoses, treatment 3Health News:Simon Ourian, Kim Kardashian's Cosmetic Surgeon, Warns About Illegal Use of Expression as a Dermal Filler 2Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2
... The following is the text of a letter to Senator ... Honorable Harry Reid , Majority Leader , United States Senate , ... health care reform debate very carefully. We applaud you and the ... most important and most difficult public policy issue. And, we applaud ...
... MOUNTAIN VIEW, Calif., Oct. 9 The Business & ... to announce its 2009 Quarterly Analyst Briefing Presentation entitled ... Analysis to be held on Tuesday, October 13, ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , The past year has ushered in ...
... quarter 2009 earnings release (expected to be issued after market close on ... invite you to listen to its quarterly investor conference call that will ... 9:00 a.m. ET. , , What: Covance ... October 22, 2009, 9:00 a.m. ET*, Where: ...
... predict , FRIDAY, Oct. 9 (HealthDay News) -- A ... blood sugar control, say U.S. researchers who conducted lab ... as genetically engineered mice. , "The most surprising part ... are embedded directly into another pathway, one that is ...
... (ASH) is proud to announce the participants in ... hematologic capacity in developing countries. Through this program, ... valuable clinical, laboratory, or technological training on a ... mentorship of an ASH member anywhere in the ...
... hospitals given awards for following program , FRIDAY, Oct. ... patients are less likely to die if they,re treated ... American Heart Association,s Get With The Guidelines (GWTG) quality ... Centers for Medicare and Medicaid Services data on 30-day ...
Cached Medicine News:Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 2Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 3Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 4Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 5Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 6Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 7Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 8Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 9Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 10Health News:Frost & Sullivan to Discuss Investment Patterns in the Healthcare Industry in Free Webinar 2Health News:Body Clock, Blood Sugar Control Seem Linked 2Health News:Medical professionals from developing nations to pursue hematology training 2Health News:American Heart Association Guidelines Save Lives 2
(Date:9/17/2014)... , Sept. 17, 2014  Levi & Korsinsky, ... connection with possible claims of breaches of fiduciary duty ... To get more information, click here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa ... If you own common stock in Alexza ... contact Eduard Korsinsky, Esq. either via email ...
(Date:9/17/2014)... /PRNewswire-iReach/ -- ChemImage announced today the release ... the development of imaging technology used to ... diseased tissue that minimizes the learning curve, ... surgical costs and potentially enhances patient outcomes ... The clinical and scientific teams at ChemImage ...
(Date:9/17/2014)... 2014 Bronstein, Gewirtz & Grossman, LLC is ... securities of PDL BioPharma, Inc. ("PDL BioPharma" or the ... are advised to contact Peretz Bronstein or ... info@bgandg.com or 212-697-6484. The investigation ... executives violated federal securities laws. On September ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
... incisional corneal surgery has long ... of the ophthalmology practice. To ... the technical skills and a ... quality. The new "Newman Astigmatic ...
The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology....
... is indicated for the treatment of ... as telangiectasia, rosacea, spider angiomas, cherry ... papulosis nigra and keratoses. Patented ... selection of handpieces maximizes versatility, compact ...
... handpieces, used for endophotocoagulation ... with uncompromised laser treatment ... EndoProbe handpieces are compatible ... green (532 nm), OcuLight ...
Medicine Products: